EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FORMULATION OF DENTAL ANESTHETIC GEL CONTAINING EUGENOL EXTRACTED FROM OCIMUM SANCTUM

Dr. Benish Tufail, Dr. Bibi Gul Sama, Dr. Muhammad Arif Shaikh

Journal of Medical & Health Sciences Review · 15.04.2026 · 3 (2) · 130-142

DOI: 10.65035/hha7ca58 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical & Health Sciences Review, online erschienen am 15.04.2026. Verfasst von Dr. Benish Tufail und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Topical anesthetic agents are effective in dentistry, but are likely to have short duration of action and adverse effects.

Objective

To design and determine a mucoadhesive dental gel with eugenol derived using Ocimum sanctum and determine its physicochemical characteristics, antimicrobial activity, and clinical anesthetic activity. Methodology: The present experimental pharmaceutical research was carried out by extracting eugenol-rich essential oil of Ocimum sanctum, and preparation of carbopol-based mucoadhesive gels (F1–F3). Physicochemical analysis, in vitro drug release, antimicrobial analysis, stability analysis, and a randomized single-blind clinical pilot study were conducted. One hundred patients were recruited and divided into five (placebo, lidocaine, F1, F2 and F3; n = 20 each) groups to evaluate pain on the Visual Analog Scale (VAS), time of onset and duration of action.

Results

The extraction yielded 2.4 ± 0.12% essential oil with 72.0 ± 1.5% eugenol content. The optimized formulation (F3) showed pH 6.60 ± 0.05, viscosity 3600 ± 75 cP, mucoadhesive strength 26.8 ± 0.4 g, and sustained drug release of 88 ± 1.2% at 12 hours. Antimicrobial activity demonstrated inhibition zones of 20 ± 0.4 mm (S. mutans), 19 ± 0.5 mm (S. aureus), and 18 ± 0.5 mm (C. albicans). In clinical evaluation, F3 significantly reduced pain with a VAS score of 2.3 ± 0.2 compared to placebo 6.8 ± 0.4, with 92.5% patient satisfaction, onset time of 55 ± 4 seconds, and duration of 40 ± 4 minutes. No adverse events were observed in the F3 group (0%).

Conclusion

The developed eugenol-based mucoadhesive dental gel demonstrated effective topical anesthetic, antimicrobial, and biocompatible properties.

Zitieren

APA

Tufail, D. B., Sama, D. B. G., & Shaikh, D. M. A. (2026). FORMULATION OF DENTAL ANESTHETIC GEL CONTAINING EUGENOL EXTRACTED FROM OCIMUM SANCTUM. Journal of Medical & Health Sciences Review, 3(2), 130-142. https://doi.org/10.65035/hha7ca58

Vancouver

Tufail DB, Sama DBG, Shaikh DMA. FORMULATION OF DENTAL ANESTHETIC GEL CONTAINING EUGENOL EXTRACTED FROM OCIMUM SANCTUM. Journal of Medical & Health Sciences Review. 2026;3(2):130-142. doi:10.65035/hha7ca58

BibTeX
@article{Tufail2026,
  author = {Tufail, Dr. Benish and Sama, Dr. Bibi Gul and Shaikh, Dr. Muhammad Arif},
  title = {FORMULATION OF DENTAL ANESTHETIC GEL CONTAINING EUGENOL EXTRACTED FROM OCIMUM SANCTUM},
  journal = {Journal of Medical & Health Sciences Review},
  year = {2026},
  volume = {3},
  number = {2},
  pages = {130--142},
  doi = {10.65035/hha7ca58}
}
Kostenlos starten →